NCT02861417 2026-02-17Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantM.D. Anderson Cancer CenterPhase 2 Active not recruiting204 enrolled
NCT00513474 2017-05-25Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantMassachusetts General HospitalPhase 1 Completed46 enrolled 11 charts